This anti-hepatic steatosis effect of BBR is attributable to, at least in part, the actions of BBR on reducing the methylation of the microsomal triglyceride transfer protein (MTTP) promoter19 and on decreasing the DNA demethylation and histone acetylation in regulation of L-pyruvate kinase22. Here, MTTP is linked to Hepatic steatosis.